Two Sigma Investments’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-8,900
Closed -$1.34M 4266
2021
Q4
$1.34M Buy
8,900
+4,900
+123% +$661K ﹤0.01% 2296
2021
Q3
$478K Sell
4,000
-10,000
-71% -$1.1M ﹤0.01% 3307
2021
Q2
$1.36M Buy
14,000
+2,100
+18% +$187K ﹤0.01% 2205
2021
Q1
$1.05M Sell
11,900
-25,800
-68% -$2.4M ﹤0.01% 2267
2020
Q4
$3.61M Buy
37,700
+1,600
+4% +$165K 0.01% 1119
2020
Q3
$4.1M Buy
36,100
+19,800
+121% +$2.08M 0.01% 891
2020
Q2
$1.61M Sell
16,300
-10,600
-39% -$846K 0.01% 1210
2020
Q1
$1.73M Buy
26,900
+16,900
+169% +$1.18M 0.01% 1046
2019
Q4
$596K Sell
10,000
-4,100
-29% -$253K ﹤0.01% 2643
2019
Q3
$832K Sell
14,100
-11,600
-45% -$740K ﹤0.01% 2131
2019
Q2
$1.66M Buy
+25,700
New +$1.66M 0.01% 1576
2019
Q1
Sell
-17,000
Closed -$645K 3472
2018
Q4
$645K Buy
+17,000
New +$600K ﹤0.01% 1943

Other funds holding TNDM

Two Sigma Investments's TNDM Position: Q1 2026 in Review

Two Sigma Investments increased its Tandem Diabetes Care (TNDM) stake by 55% in Q1 2026, buying an estimated $14.4M and bringing the position to 1,864,194 shares worth $35.7M. The position accounts for 0.03% of the portfolio, ranked #645.

Two Sigma Investments first reported a position in TNDM in Q1 2014 and has held it in 29 quarters since. The position peaked at $56.7M in Q1 2019. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • Two Sigma Investments held 1,864,194 shares of Tandem Diabetes Care worth $35.7M as of Q1 2026.
  • Two Sigma Investments bought 662,667 Tandem Diabetes Care shares in Q1 2026, an estimated $14.4M.
  • Tandem Diabetes Care made up 0.03% of Two Sigma Investments's portfolio in Q1 2026, its #645 holding.
  • Two Sigma Investments first reported a position in Tandem Diabetes Care in Q1 2014 and has held it in 29 quarters since.
  • Two Sigma Investments's Tandem Diabetes Care position peaked at $56.7M in Q1 2019.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.